Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Personalized Medical Devices Market: By Therapeutic Area By Application, By End User, By Geography
Personalized Medical Devices Market size was valued at US$ 594.1 billion in 2023 and is expected to growth at a CAGR of 6.3% 2024 to 2030. Personalized Medical Devices (PM) can possibly tailor made devices with the best reaction and most noteworthy security edge to guarantee better patient care. By empowering every patient to get prior judgments, chance appraisals, and ideal medications, Personalized Medical Devices Market holds guarantee for enhancing medicinal services while additionally bringing down expenses. Medical devices companies are encountering aggressive and taken a toll weight from various sides. On one hand, rivalry emerging from developing markets requests high-volume, straightforward gadgets with bring down costs, applying weight on costs all around. Then again, organizations confront aggressive weight from new wellsprings of medicinal gadget development like added substance fabricating, which empowers unique produce of patient-particular careful instruments and implants. Some of the examples for personalized medical devices Tinnitus masker is customized by the producer to understanding tinnitus.The tinnitus treatment custom-tailors the sound signs to suit the individual patient's listening ability necessities Pedicle screw spinal frameworks Spinal frameworks comprising of a bar/screw/snare/connector unit are amassed by a specialist to oblige a patient's interesting life systems/physiology utilizing MRI/CT imaging. Programming based quantitative EEG investigation intended to anticipate a person's reaction to different psychotropic medications. The gadget gives the likelihood of reaction to different solutions to direct clinician in basic leadership. The Zenith Fenestrated AAA Endovascular Graft is demonstrated for the endovascular treatment of patients with stomach aortic or aortoiliac aneurysms having morphology reasonable for endovascular repair. The fenestrated gadget takes into account treatment of patients with shorter proximal neck lengths (i.e., length of solid aorta between the renal corridors and the aneurysm) when contrasted with the individuals who can be dealt with utilizing other endovascular joins. Every gadget is customized to the patient's individual aortic life structures with openings in the join material set suitably to keep up blood stream to branch vessels of the aorta. The Artificial Pancreas Device System is a gadget under clinical examination that naturally screens understanding glucose levels and conveys persistent customized insulin measurements in individuals with diabetes.
Study Period
2024-2030Base Year
2023CAGR
6.3%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Personalized Medical Devices market is relied upon to witness fast development because of expanding illness occurrence and profound focal point of launching new products for tumor patients where viability has been turned out to be higher when contrasted with different treatments. Quick outcomes and tweaked impacts, bring down likelihood of prescription defects and unfriendly medication responses are a portion of alternate factors that could make reasonable footing in both R&D and income potential for these solutions. Late advancements in the pharmacogenomics are relied upon to make appropriate condition for developing devices, which are particular to one patient or gathering. Advancement of hereditary databases could give extra lift to the market. Up and coming remedial application openings in fields, for example, cardio-renal, neurology, antiviral, pneumonic, psychiatry among others could make R&D footing over all locales. High advancement costs, problematic improvement structure and between understanding changeability of impacts are a portion of the limitations that could hamper income development of the Personalized Medical Devices market.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 594.1 billion |
Market CAGR |
6.3% |
By Therapeutic Area |
|
By Application |
|
By End User |
|
By Region |
|
Download Free Sample Report
2023 is the base year and 2030 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Personalized Medical Devices Market size was valued at US$ 594.1 billion in 2023 and is expected to growth at a CAGR of 6.3% 2024 to 2030.
1.Executive Summary |
2.Global Personalized Medical Devices Market Introduction |
2.1.Global Personalized Medical Devices Market - Taxonomy |
2.2.Global Personalized Medical Devices Market - Definitions |
2.2.1.Therapeutic Area |
2.2.2.Application |
2.2.3.End User |
2.2.4.Region |
3.Global Personalized Medical Devices Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Personalized Medical Devices Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Personalized Medical Devices Market By Therapeutic Area, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Neurology |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Oncology |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Cardiology |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Psychiatry |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Antiviral |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Others |
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
6.Global Personalized Medical Devices Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Companion Diagnostics |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Biomarker identification |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Health Informatics |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Clinical Research |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7.Global Personalized Medical Devices Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Molecular Diagnostic Laboratories and Testing facilities |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Homecare settings |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Others |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8.Global Personalized Medical Devices Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Personalized Medical Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Neurology |
9.1.2.Oncology |
9.1.3.Cardiology |
9.1.4.Psychiatry |
9.1.5.Antiviral |
9.1.6.Others |
9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Companion Diagnostics |
9.2.2.Biomarker identification |
9.2.3.Health Informatics |
9.2.4.Clinical Research |
9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Molecular Diagnostic Laboratories and Testing facilities |
9.3.3.Homecare settings |
9.3.4.Others |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Personalized Medical Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Therapeutic Area Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Neurology |
10.1.2.Oncology |
10.1.3.Cardiology |
10.1.4.Psychiatry |
10.1.5.Antiviral |
10.1.6.Others |
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Companion Diagnostics |
10.2.2.Biomarker identification |
10.2.3.Health Informatics |
10.2.4.Clinical Research |
10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Molecular Diagnostic Laboratories and Testing facilities |
10.3.3.Homecare settings |
10.3.4.Others |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
10.4.7. |
11.Asia Pacific (APAC) Personalized Medical Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Therapeutic Area Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Neurology |
11.1.2.Oncology |
11.1.3.Cardiology |
11.1.4.Psychiatry |
11.1.5.Antiviral |
11.1.6.Others |
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Companion Diagnostics |
11.2.2.Biomarker identification |
11.2.3.Health Informatics |
11.2.4.Clinical Research |
11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Molecular Diagnostic Laboratories and Testing facilities |
11.3.3.Homecare settings |
11.3.4.Others |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Personalized Medical Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Therapeutic Area Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Neurology |
12.1.2.Oncology |
12.1.3.Cardiology |
12.1.4.Psychiatry |
12.1.5.Antiviral |
12.1.6.Others |
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Companion Diagnostics |
12.2.2.Biomarker identification |
12.2.3.Health Informatics |
12.2.4.Clinical Research |
12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Molecular Diagnostic Laboratories and Testing facilities |
12.3.3.Homecare settings |
12.3.4.Others |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Personalized Medical Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Therapeutic Area Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Neurology |
13.1.2.Oncology |
13.1.3.Cardiology |
13.1.4.Psychiatry |
13.1.5.Antiviral |
13.1.6.Others |
13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Companion Diagnostics |
13.2.2.Biomarker identification |
13.2.3.Health Informatics |
13.2.4.Clinical Research |
13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Molecular Diagnostic Laboratories and Testing facilities |
13.3.3.Homecare settings |
13.3.4.Others |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Becton, Dickinson and Company (USA) |
14.2.2.Abbott Laboratories, Inc. (USA) |
14.2.3.bioMerieux, Inc. (France) |
14.2.4.Biomerica, Inc.(USA) |
14.2.5.Olympus Corporation (Japan) |
14.2.6.Qiagen N.V. (Geramany) |
14.2.7.Siemens AG (Germany) |
14.2.8.Thermo Fischer Scientific, Inc. (USA). |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players